InvestorsHub Logo
Followers 7
Posts 871
Boards Moderated 0
Alias Born 07/08/2013

Re: None

Monday, 03/15/2021 4:24:33 PM

Monday, March 15, 2021 4:24:33 PM

Post# of 5321
Considering the importance of a person’s level of neutralizing antibody as an acceptable person to do certain work or to be of acceptable international traveling status , AXIM seems to be under the radar.

One possible threat to this potential value for AXIM is if there are other companies with similar technology that is superior or is in direct competition with ImmunoPass.

There is rarely a case where we investors have perfect knowledge of the capability of our competition and what they have already or will in the future achieve.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News